Skip to main content
Top
Published in: The International Journal of Cardiovascular Imaging 1/2010

01-01-2010 | Original Paper

Evaluation of vascular reactivity of young male hypogonadotrophic hypogonadism patients

Authors: Ferhat Deniz, Necip Ermiş, Alper Kepez, Barış Türk, Murat Akkoyunlu, Batuhan Kara, Mustafa Kutlu

Published in: The International Journal of Cardiovascular Imaging | Issue 1/2010

Login to get access

Abstract

We aimed to study the vascular reactivity of young male hypogonadal hypogonadism patients without any cardiovascular risk factors and compare these findings with the ones of age-matched healthy controls. Study population consisted of 26 young male hypogonadotrophic hypogonadism patients (20.9 ± 1.3 years) and 25 age-matched healthy male controls (21.8 ± 2.9 years, P = NS). In addition to detailed hormonal analysis, each subject underwent ultrasound study of right brachial artery. Vessel diameter was measured at rest, during reactive hyperemia [endothelium-dependent flow-mediated vasodilation (FMD)] and after sublingual nitroglycerin administration (endothelium-independent vasodilation). Both flow-mediated and endothelium-independent sublingual nitroglycerin mediated dilatation values of patients were higher compared to controls (12.98 ± 10.76% vs. 7.92 ± 1.96%, P = 0.003 and 21.44 ± 10.36% vs. 14.72 ± 3.57%, P = 0.023, respectively). Linear regression analysis revealed that only serum HDL levels (relative risk 2.94, 95% CI 0.12–0.66, P = 0.006) and baseline vessel diameter (relative risk −2.77, 95% CI −17.73 to −2.70, P = 0.009) were found to be independently associated with FMD values. Endogenous male sex hormones seem to exert negative effects on vascular reactivity parameters and much of their effects are indirect that is by the way of alteration on lipid profile.
Literature
1.
go back to reference Kalin MF, Zumoff B (1990) Sex hormones and coronary artery disease: a review of the clinical studies. Steroids 55:330–352CrossRefPubMed Kalin MF, Zumoff B (1990) Sex hormones and coronary artery disease: a review of the clinical studies. Steroids 55:330–352CrossRefPubMed
2.
go back to reference Liu PY, Death AK, Handelsman DJ (2003) Androgens and cardiovascular disease. Endocr Rev 24:313–340CrossRefPubMed Liu PY, Death AK, Handelsman DJ (2003) Androgens and cardiovascular disease. Endocr Rev 24:313–340CrossRefPubMed
3.
go back to reference Lerner DJ, Kannel WB (1986) Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 111:383–390CrossRefPubMed Lerner DJ, Kannel WB (1986) Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 111:383–390CrossRefPubMed
4.
go back to reference Adams MR, Kaplan JR, Manuck SB et al (1990) Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys: lack of an effect of added progesterone. Atherosclerosis 10:1051–1057 Adams MR, Kaplan JR, Manuck SB et al (1990) Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys: lack of an effect of added progesterone. Atherosclerosis 10:1051–1057
5.
go back to reference Wagner JD, Clarkson TB, Clair RWS, Schwenke DC, Shively CA, Adams MR (1991) Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys. J Clin Invest 88:1995–2002 Wagner JD, Clarkson TB, Clair RWS, Schwenke DC, Shively CA, Adams MR (1991) Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys. J Clin Invest 88:1995–2002
6.
go back to reference Kaplan JR, Manuck SB, Anthony MS, Clarkson TB (2002) Premenopausal social status and hormone exposure predict postmenopausal atherosclerosis in female monkeys. Obstet Gynecol 99:381–388CrossRefPubMed Kaplan JR, Manuck SB, Anthony MS, Clarkson TB (2002) Premenopausal social status and hormone exposure predict postmenopausal atherosclerosis in female monkeys. Obstet Gynecol 99:381–388CrossRefPubMed
7.
go back to reference Paoletti R, Cosignani PG, Kenemans P et al (1997) Menopause: problems and interventions in the United States. In: Paoletti R, Cosignani PG, Kenemans P, Samsoe G, Soma M, Jackson AS (eds) Women’s health and menopause. Kluwer Academic Publishers, Norwell, MA, pp 9–14 Paoletti R, Cosignani PG, Kenemans P et al (1997) Menopause: problems and interventions in the United States. In: Paoletti R, Cosignani PG, Kenemans P, Samsoe G, Soma M, Jackson AS (eds) Women’s health and menopause. Kluwer Academic Publishers, Norwell, MA, pp 9–14
8.
go back to reference Liu PY, Death AK, Handelsman DJ et al (2003) Androgens and cardiovascular disease. Endocr Rev 24:313–340CrossRefPubMed Liu PY, Death AK, Handelsman DJ et al (2003) Androgens and cardiovascular disease. Endocr Rev 24:313–340CrossRefPubMed
9.
go back to reference Hanke H, Lenz C, Hess B et al (2001) Effect of testosterone on plaque development and androgen receptor expression in the arterial vessel wall. Circulation 103:1382–1385PubMed Hanke H, Lenz C, Hess B et al (2001) Effect of testosterone on plaque development and androgen receptor expression in the arterial vessel wall. Circulation 103:1382–1385PubMed
10.
go back to reference Larsen BA, Nordestgaard BG, Stender S et al (1993) Effect of testosterone on atherogenesis in cholesterol-fed rabbits with similar plasma cholesterol levels. Atherosclerosis 99:79–86CrossRefPubMed Larsen BA, Nordestgaard BG, Stender S et al (1993) Effect of testosterone on atherogenesis in cholesterol-fed rabbits with similar plasma cholesterol levels. Atherosclerosis 99:79–86CrossRefPubMed
11.
go back to reference Nathan L, Shi W, Dinh H et al (2001) Testosterone inhibits early atherogenesis by conversion to estradiol: critical role of aromatase. Proc Natl Acad Sci USA 98:3589–3593CrossRefPubMed Nathan L, Shi W, Dinh H et al (2001) Testosterone inhibits early atherogenesis by conversion to estradiol: critical role of aromatase. Proc Natl Acad Sci USA 98:3589–3593CrossRefPubMed
12.
go back to reference Alexandersen P, Haarbo J, Byrjalsen I et al (1999) Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits. Circ Res 84:813–819PubMed Alexandersen P, Haarbo J, Byrjalsen I et al (1999) Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits. Circ Res 84:813–819PubMed
13.
go back to reference Bruck B, Brehme U, Gugel N et al (1997) Gender-specific differences in the effects of testosterone and estrogen on the development of atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol 17:2192–2199PubMed Bruck B, Brehme U, Gugel N et al (1997) Gender-specific differences in the effects of testosterone and estrogen on the development of atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol 17:2192–2199PubMed
14.
go back to reference Deenadayalu VP, White RE, Stallone JN et al (2001) Testosterone relaxes coronary arteries by opening the large-conductance, calcium-activated potassium channel. Am J Physiol Heart Circ Physiol 281:1720–1727 Deenadayalu VP, White RE, Stallone JN et al (2001) Testosterone relaxes coronary arteries by opening the large-conductance, calcium-activated potassium channel. Am J Physiol Heart Circ Physiol 281:1720–1727
15.
go back to reference Yue P, Chatterjee K, Beale C et al (1995) Testosterone relaxes rabbit coronary arteries and aorta. Circulation 91:1154–1160PubMed Yue P, Chatterjee K, Beale C et al (1995) Testosterone relaxes rabbit coronary arteries and aorta. Circulation 91:1154–1160PubMed
16.
go back to reference Moens AL, Goovaerts I, Claeys MJ et al (2005) Flow-mediated vasodilation: a diagnostic instrument, or an experimental tool? Chest 127:2254–2263CrossRefPubMed Moens AL, Goovaerts I, Claeys MJ et al (2005) Flow-mediated vasodilation: a diagnostic instrument, or an experimental tool? Chest 127:2254–2263CrossRefPubMed
17.
go back to reference McCredie RJ, McCrohon JA, Turner L et al (1998) Vascular reactivity is impaired in genetic females taking high-dose androgens. J Am Coll Cardiol 32:1331–1335CrossRefPubMed McCredie RJ, McCrohon JA, Turner L et al (1998) Vascular reactivity is impaired in genetic females taking high-dose androgens. J Am Coll Cardiol 32:1331–1335CrossRefPubMed
18.
go back to reference Herman MS, Robinson JTC, McCredie RJ et al (1997) Androgen deprivation is associated with enhanced endothelium-dependent dilatation in adult men. Arterioscler Thromb Vasc Biol 17:2004–2009PubMed Herman MS, Robinson JTC, McCredie RJ et al (1997) Androgen deprivation is associated with enhanced endothelium-dependent dilatation in adult men. Arterioscler Thromb Vasc Biol 17:2004–2009PubMed
19.
go back to reference Sader MA, Griffiths KA, McCredie RJ et al (2001) Androgenic anabolic steroids and arterial structure and function in male bodybuilders. J Am Coll Cardiol 37:224–230CrossRefPubMed Sader MA, Griffiths KA, McCredie RJ et al (2001) Androgenic anabolic steroids and arterial structure and function in male bodybuilders. J Am Coll Cardiol 37:224–230CrossRefPubMed
20.
go back to reference Zitzmann M, Brune M, Nieschlag E et al (2002) Vascular reactivity in hypogonadal men is reduced by androgen substitution. J Clin Endocrinol Metab 87:5030–5037CrossRefPubMed Zitzmann M, Brune M, Nieschlag E et al (2002) Vascular reactivity in hypogonadal men is reduced by androgen substitution. J Clin Endocrinol Metab 87:5030–5037CrossRefPubMed
21.
go back to reference Bernini G, Versari D, Moretti A et al (2006) Vascular reactivity in congenital hypogonadal men before and after testosterone replacement therapy. J Clin Endocrinol Metab 91:1691–1697CrossRefPubMed Bernini G, Versari D, Moretti A et al (2006) Vascular reactivity in congenital hypogonadal men before and after testosterone replacement therapy. J Clin Endocrinol Metab 91:1691–1697CrossRefPubMed
22.
go back to reference Sader MA, Griffiths KA, Skilton MR et al (2003) Physiological testosterone replacement and arterial endothelial function in men. Clin Endocrinol 59:62–67CrossRef Sader MA, Griffiths KA, Skilton MR et al (2003) Physiological testosterone replacement and arterial endothelial function in men. Clin Endocrinol 59:62–67CrossRef
23.
go back to reference Webb OL, Laskarzewski PM, Glueck CJ (1984) Severe depression of high-density lipoprotein cholesterol levels in weight lifters and body builders by self-administered exogenous testosterone and anabolic androgenic steroids. Metabolism 33:971–975CrossRefPubMed Webb OL, Laskarzewski PM, Glueck CJ (1984) Severe depression of high-density lipoprotein cholesterol levels in weight lifters and body builders by self-administered exogenous testosterone and anabolic androgenic steroids. Metabolism 33:971–975CrossRefPubMed
24.
go back to reference Thompson PD, Cullinane EM, Sady SP et al (1989) Contrasting effects of testosterone and stanazolol on serum lipoprotein levels. JAMA 261:1165–1168CrossRefPubMed Thompson PD, Cullinane EM, Sady SP et al (1989) Contrasting effects of testosterone and stanazolol on serum lipoprotein levels. JAMA 261:1165–1168CrossRefPubMed
25.
go back to reference Anderson TJ, Uehata A, Gerhard MD et al (1995) Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 26:1235–1241CrossRefPubMed Anderson TJ, Uehata A, Gerhard MD et al (1995) Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 26:1235–1241CrossRefPubMed
Metadata
Title
Evaluation of vascular reactivity of young male hypogonadotrophic hypogonadism patients
Authors
Ferhat Deniz
Necip Ermiş
Alper Kepez
Barış Türk
Murat Akkoyunlu
Batuhan Kara
Mustafa Kutlu
Publication date
01-01-2010
Publisher
Springer Netherlands
Published in
The International Journal of Cardiovascular Imaging / Issue 1/2010
Print ISSN: 1569-5794
Electronic ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-009-9505-7

Other articles of this Issue 1/2010

The International Journal of Cardiovascular Imaging 1/2010 Go to the issue